Oncology
We have access to state-of-the-art laboratories and are conducting cutting edge research into targeted therapies for cancer, diagnostic biomarkers to detect prostate cancer from patient urine and also biomarkers which will aid diagnosis and prognosis of prostate cancer.
Research areas
- Gene targeting
- Therapies
- Biomarkers
- Clinical trials
Targeted Cancer Therapy Research Group
The Targeted Cancer Therapy Group in the Section of Oncology is headed by Professor Hardev Pandha and is based at the Leggett building. The group has access to state of the art laboratories and are conducting cutting edge research into targeted therapies for cancer, diagnostic biomarkers to detect prostate cancer from patient urine and also biomarkers which will aid diagnosis and prognosis of prostate cancer.
Meet the team
Team lead
Dr Mohammad Asim
Assistant Professor & Group Leader in Cancer Biology & Therapeutics
Team members
Dr Tony Dhillon
Senior Lecturer in Oncology, University of Surrey, Consultant Medical Oncologist, Royal Surrey County Hospital
Dr Adam Frampton
Vice-Chancellor's Fellow and Senior Lecturer in Surgical Oncology; Consultant General & Hepato-Pancreato-Biliary (HPB) Surgeon
Dr Agnieszka Michael
Associate Professor in Oncology , Consultant Medical Oncologist, Medical Director of Surrey CTU
Professor Hardev Pandha
Professor of Medical Oncology
Dr Kate Relph
Project manager